Citi Pharma Ltd
KAR:CPHL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Citi Pharma Ltd
KAR:CPHL
|
PK |
|
P
|
Pensana PLC
F:48W
|
UK |
|
R
|
Rtx A/S
F:RTE
|
DK |
|
S
|
Spacetalk Ltd
F:EZY
|
AU |
|
J
|
Jungheinrich AG
XHAN:JUN3
|
DE |
|
T
|
Tatung System Technologies Inc
TPEX:8099
|
TW |
|
A
|
Atinum Investment Co Ltd
KOSDAQ:021080
|
KR |
|
Caesarstone Ltd
NASDAQ:CSTE
|
IL |
|
E
|
EPIC Suisse AG
SIX:EPIC
|
CH |
|
Nykode Therapeutics ASA
F:5VB
|
NO |
|
A
|
Andritz AG
XMUN:AZ2
|
AT |
|
Grodno SA
F:WO7
|
PL |
|
H
|
Hanil Forging Industrial
KOSDAQ:024740
|
KR |
|
I
|
Ingenia Communities Group
OTC:INGEF
|
AU |
|
D
|
Daea TI Co Ltd
KOSDAQ:045390
|
KR |
|
E
|
EDU Holdings Ltd
ASX:EDU
|
AU |
|
GEK Terna SA
F:1GT
|
GR |
Bankruptcy Probability
Citi Pharma Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Citi Pharma Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PK |
C
|
Citi Pharma Ltd
KAR:CPHL
|
14.6B PKR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
617.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
351.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
346.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
223.8B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
186.1B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
324.7B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
158.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
121.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Citi Pharma Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Citi Pharma Ltd has total debt of 3.5B PKR. This includes both short-term (3.4B PKR) and long-term (83.9m PKR) debt.
You can find a full breakdown on its Balance Sheet.